Forkhead Biotherapeutics, Inc.
PrivateCompany Overview
Forkhead Biotherapeutics, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. It was founded in 2017.
Forkhead Biotherapeutics, Inc. is a biotechnology company that develops oral therapies for insulin-dependent diabetes by harnessing cell conversion and regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forkhead Biotherapeutics, Inc. Comparables
Compare Forkhead Biotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 81% | |
| Altay Therapeutics | 81% | |
| Recludix Pharma | 79% |
For institutional investors. Book with your work email.
Forkhead Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
Forkhead Biotherapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Forkhead Biotherapeutics, Inc.'s valuation, stock price, and market status.
Is Forkhead Biotherapeutics, Inc. a public or private company?
Forkhead Biotherapeutics, Inc. is a private company.
What is the current stock price of Forkhead Biotherapeutics, Inc.?
Forkhead Biotherapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Forkhead Biotherapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Forkhead Biotherapeutics, Inc. worth (valuation)?
Valuation information for Forkhead Biotherapeutics, Inc. is not publicly available.
Can I buy Forkhead Biotherapeutics, Inc. stock?
Forkhead Biotherapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Forkhead Biotherapeutics, Inc.'s last funding round?
Funding round information for Forkhead Biotherapeutics, Inc. is not publicly available.
Who are the main investors in Forkhead Biotherapeutics, Inc.?
Investor information for Forkhead Biotherapeutics, Inc. is not publicly disclosed.
Will Forkhead Biotherapeutics, Inc. IPO soon?
No public IPO plans have been announced for Forkhead Biotherapeutics, Inc..
How can I track Forkhead Biotherapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Forkhead Biotherapeutics, Inc.'s shares on secondary markets.